Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Prostate Cancer

  Free Subscription


02.09.2024

1 Anticancer Res
6 BJU Int
3 BMC Urol
1 Br J Radiol
1 Cancer Imaging
1 Eur J Radiol
1 Eur Urol
1 Int J Urol
1 J Nucl Med
1 Nat Rev Urol
1 Proc Natl Acad Sci U S A
1 Prostate
1 Radiol Imaging Cancer
1 Ther Adv Urol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Anticancer Res

  1. SATO M, Sato T, Hozumi C, Han Q, et al
    [(11)C]Methionine PET vs. [(18)F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients.
    Anticancer Res. 2024;44:3891-3898.
    PubMed         Abstract available


    BJU Int

  2. REIJNDERS-BOERBOOM GTJA, Jacobs LMC, Helder LS, Panhuizen IF, et al
    Recovery and immune function after low pressure pneumoperitoneum during robot-assisted radical prostatectomy: a randomised controlled trial.
    BJU Int. 2024;134:416-425.
    PubMed         Abstract available


  3. Advances in the detection and treatment of prostate cancer plus d-mannose for the prevention of recurrent UTIs.
    BJU Int. 2024;134:321-322.
    PubMed        

  4. BATES AS, Sharma AD, Camilleri P, Browning L, et al
    'Case of the Month' from the Department of Urology, Oxford University Hospitals, Oxford, UK: stereotactic radiotherapy to the vas deferens for PSMA-PET CT detected local recurrence 10 years after radical prostatectomy.
    BJU Int. 2024;134:377-379.
    PubMed        

  5. TAKAHASHI T
    Observational study on screen-detected prostate cancer: case series of empirical clinical practice.
    BJU Int. 2024 Aug 29. doi: 10.1111/bju.16525.
    PubMed        

  6. TOUZANI A, D'Agate D, Kesch C, Calleris G, et al
    One-year outcomes of same-day-discharge robot-assisted radical prostatectomy.
    BJU Int. 2024;134:380-382.
    PubMed        

  7. OUCHI M, Kitta T, Chiba H, Higuchi M, et al
    Physiotherapy for continence and muscle function in prostatectomy: a randomised controlled trial.
    BJU Int. 2024;134:398-406.
    PubMed         Abstract available


    BMC Urol

  8. HAO S, Wang H, Lin S, Chen H, et al
    Analysis of risk factors for persistent PSA after radical prostatectomy: results from a high-volume center in Southeast China.
    BMC Urol. 2024;24:185.
    PubMed         Abstract available

  9. CLAASSEN K, Karpinski M, Kajuter H, Husing J, et al
    Mortality from prostate cancer in the years 2007-2021 in North Rhine-Westphalia, Germany.
    BMC Urol. 2024;24:181.
    PubMed         Abstract available

  10. ALASKER A, Alsalamah S, Alshathri N, Almansour N, et al
    Performance of large language models (LLMs) in providing prostate cancer information.
    BMC Urol. 2024;24:177.
    PubMed         Abstract available


    Br J Radiol

  11. PARK SH, Choi MH, Lee YJ, Jung SE, et al
    Rationale for Adopting a Combination of Monoparametric MRI with the Prostate-Specific Antigen in Detecting Clinically Significant Prostate Cancer: Comparison with Standard Biparametric and Multiparametric MRI.
    Br J Radiol. 2024 Aug 30:tqae134. doi: 10.1093.
    PubMed         Abstract available


    Cancer Imaging

  12. HARSINI S, Martineau P, Plaha S, Saprunoff H, et al
    Prognostic significance of a negative PSMA PET/CT in biochemical recurrence of prostate cancer.
    Cancer Imaging. 2024;24:117.
    PubMed         Abstract available


    Eur J Radiol

  13. BECKER AS, Woo S, Leithner D, Tong A, et al
    The "Hungry Judge" effect on prostate MRI reporting: Chronobiological trends from 35'004 radiologist interpretations.
    Eur J Radiol. 2024;179:111665.
    PubMed         Abstract available


    Eur Urol

  14. LEENEN RCA, Venderbos LDF, Helleman J, Gomez Rivas J, et al
    Prostate Cancer Early Detection in the European Union and UK.
    Eur Urol. 2024 Aug 24:S0302-2838(24)02502-8. doi: 10.1016/j.eururo.2024.
    PubMed         Abstract available


    Int J Urol

  15. MATSUOKA Y
    Editorial Comment to "Can the Briganti 2019 nomogram be modified to predict lymph node metastasis risk in patients with prostate cancer detected with in-bore biopsy?".
    Int J Urol. 2024 Aug 24. doi: 10.1111/iju.15566.
    PubMed        


    J Nucl Med

  16. WONG AJN, Ko HS, Hofman MS
    Navigating the Future of Prostate Cancer Care: AI-Driven Imaging and Theranostics Through the Lens of RELAINCE.
    J Nucl Med. 2024 Aug 29:jnumed.124.267924. doi: 10.2967/jnumed.124.267924.
    PubMed        


    Nat Rev Urol

  17. LUNJ S, Smith TAD, Reeves KJ, Currell F, et al
    Immune effects of alpha and beta radionuclides in metastatic prostate cancer.
    Nat Rev Urol. 2024 Aug 27. doi: 10.1038/s41585-024-00924.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  18. SU XA, Stopsack KH, Schmidt DR, Ma D, et al
    RAD21 promotes oncogenesis and lethal progression of prostate cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2405543121.
    PubMed         Abstract available


    Prostate

  19. TSAI K, Xu P, Guo J, Dean N, et al
    Do Prostate Imaging-Reporting and Data System (PIRADS) lesions predict holmium laser enucleation of prostate outcomes?
    Prostate. 2024;84:1344-1351.
    PubMed         Abstract available


    Radiol Imaging Cancer

  20. BITTON RR, Shao W, Chodakeiwitz Y, Brunsing RL, et al
    Intraprocedural Diffusion-weighted Imaging for Predicting Ablation Zone during MRI-guided Focused Ultrasound of Prostate Cancer.
    Radiol Imaging Cancer. 2024;6:e240009.
    PubMed         Abstract available


    Ther Adv Urol

  21. FENOR DE LA MAZA MD, Perez Gracia JL, Minana B, Castro E, et al
    PARP inhibitors alone or in combination for prostate cancer.
    Ther Adv Urol. 2024;16:17562872241272929.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.